Ham J, Yang W, Kim H
Immune Netw. 2025; 25(1):e3.
PMID: 40078781
PMC: 11896661.
DOI: 10.4110/in.2025.25.e3.
Zhang Y, Alzahrani M, Dambaeva S, Kwak-Kim J
Semin Immunopathol. 2025; 47(1):18.
PMID: 39966179
DOI: 10.1007/s00281-025-01043-y.
Clay R, Li K, Jin L
Cancers (Basel). 2025; 17(1.
PMID: 39796781
PMC: 11719658.
DOI: 10.3390/cancers17010155.
Huang K, Han Y, Chen Y, Shen H, Zeng S, Cai C
Mol Cancer. 2025; 24(1):7.
PMID: 39789606
PMC: 11716519.
DOI: 10.1186/s12943-024-02205-6.
Baumer Y, Singh K, Saurabh A, Baez A, Gutierrez-Huerta C, Chen L
JCI Insight. 2024; 10(2).
PMID: 39718832
PMC: 11790026.
DOI: 10.1172/jci.insight.180606.
Precise targeting of lipid metabolism in the era of immuno-oncology and the latest advances in nano-based drug delivery systems for cancer therapy.
Zhang H, Li Y, Huang J, Shen L, Xiong Y
Acta Pharm Sin B. 2024; 14(11):4717-4737.
PMID: 39664426
PMC: 11628863.
DOI: 10.1016/j.apsb.2024.07.021.
Stearoyl-CoA desaturase in CD4 T cells suppresses tumor growth through activation of the CXCR3/CXCL11 axis in CD8 T cells.
Hwang S, Yang Y, Jung J, Kim J, Kim Y
Cell Biosci. 2024; 14(1):137.
PMID: 39543650
PMC: 11566202.
DOI: 10.1186/s13578-024-01308-3.
Metabolic regulation of the immune system in health and diseases: mechanisms and interventions.
Hu T, Liu C, Lei M, Zeng Q, Li L, Tang H
Signal Transduct Target Ther. 2024; 9(1):268.
PMID: 39379377
PMC: 11461632.
DOI: 10.1038/s41392-024-01954-6.
Cholesterol metabolism: a positive target to revoke the function of exhausted CAR-NK cells in tumor microenvironment.
Liu J
Front Pharmacol. 2024; 15:1440869.
PMID: 39351089
PMC: 11439656.
DOI: 10.3389/fphar.2024.1440869.
Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment.
Zhang H, Li S, Wang D, Liu S, Xiao T, Gu W
Biomark Res. 2024; 12(1):96.
PMID: 39227970
PMC: 11373140.
DOI: 10.1186/s40364-024-00646-1.
The role of metabolic reprogramming in immune escape of triple-negative breast cancer.
Bao R, Qu H, Li B, Cheng K, Miao Y, Wang J
Front Immunol. 2024; 15:1424237.
PMID: 39192979
PMC: 11347331.
DOI: 10.3389/fimmu.2024.1424237.
Immunometabolism of ferroptosis in the tumor microenvironment.
Lupica-Tondo G, Arner E, Mogilenko D, Voss K
Front Oncol. 2024; 14:1441338.
PMID: 39188677
PMC: 11345167.
DOI: 10.3389/fonc.2024.1441338.
Decrease in UCP1 by sustained high lipid promotes NK cell necroptosis to exacerbate nonalcoholic liver fibrosis.
Gu M, Zhang Y, Lin Z, Hu X, Zhu Y, Xiao W
Cell Death Dis. 2024; 15(7):518.
PMID: 39033153
PMC: 11271447.
DOI: 10.1038/s41419-024-06910-4.
Fasting reshapes tissue-specific niches to improve NK cell-mediated anti-tumor immunity.
Delconte R, Owyong M, Santosa E, Srpan K, Sheppard S, McGuire T
Immunity. 2024; 57(8):1923-1938.e7.
PMID: 38878769
PMC: 11684419.
DOI: 10.1016/j.immuni.2024.05.021.
Assessing immune hepatotoxicity of troglitazone with a versatile liver-immune-microphysiological-system.
Deng Q, Yang Y, Liu Y, Zou M, Huang G, Yang S
Front Pharmacol. 2024; 15:1335836.
PMID: 38873410
PMC: 11169855.
DOI: 10.3389/fphar.2024.1335836.
Fat matters for natural killer cell activity.
Wong P, Fehniger T
Nat Immunol. 2024; 25(5):728-730.
PMID: 38637666
DOI: 10.1038/s41590-024-01825-w.
Dietary factors and their influence on immunotherapy strategies in oncology: a comprehensive review.
Golonko A, Pienkowski T, Swislocka R, Orzechowska S, Marszalek K, Szczerbinski L
Cell Death Dis. 2024; 15(4):254.
PMID: 38594256
PMC: 11004013.
DOI: 10.1038/s41419-024-06641-6.
MEF2C regulates NK cell effector functions through control of lipid metabolism.
Li J, Zhou A, Lee C, Shah S, Ji J, Senthilkumar V
Nat Immunol. 2024; 25(5):778-789.
PMID: 38589619
DOI: 10.1038/s41590-024-01811-2.
Targeting natural killer cells: from basic biology to clinical application in hematologic malignancies.
Shang J, Hu S, Wang X
Exp Hematol Oncol. 2024; 13(1):21.
PMID: 38396050
PMC: 10885621.
DOI: 10.1186/s40164-024-00481-y.
Analyzing the impact of metabolism on immune cells in tumor microenvironment to promote the development of immunotherapy.
Long Y, Shi H, He Y, Qi X
Front Immunol. 2024; 14:1307228.
PMID: 38264667
PMC: 10804850.
DOI: 10.3389/fimmu.2023.1307228.